Tapewire

Nasdaq · USD

LRMR

Larimar Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5634
SEC CIK
0001374690
Parsed reports
171

Last 12 months

Inside the activity.

8 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202670
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 29, 2026 Filed Oct 2, 2026 00:27 UTC
Harlow John B. Jr.President and COO
GrantStock Option (Right to Buy) · Derivative 800,000 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001193125-26-410719 · ownership.xml · derivative · entry 2

Harlow John B. Jr. · CIK 0002095554 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2036-09-29

F2 · derivative.exercise_date: The option vests 25% on September 29, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
September 29, 2026 Filed Oct 2, 2026 00:27 UTC
Harlow John B. Jr.President and COO
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-410719 · ownership.xml · nonDerivative · entry 1

Harlow John B. Jr. · CIK 0002095554 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
July 06, 2026 Filed Jul 8, 2026 20:05 UTC PurchaseCommon Stock 50,000 $3.34 $166,890.00
Disclosure

SEC source: 0001193125-26-298523 · ownership.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 714,798

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Read SEC document
May 19, 2026 Filed May 21, 2026 00:02 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
GrantStock Option (Right to Buy) · Derivative 55,150 $0.00 Strike: $3.33 $0.00
Disclosure

SEC source: 0001193805-26-000669 · e665501_4-larimar.xml · derivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Management Company, L.P.

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F2 · derivative.exercise_date: The option was granted on May 19, 2026 and is scheduled to vest on the earlier of May 19, 2027 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer.

F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:28 UTC GrantStock Option (Right to Buy) · Derivative 55,150 $0.00 Strike: $3.33 $0.00
Disclosure

SEC source: 0001193125-26-232667 · ownership.xml · derivative · entry 1

Truitt Joseph · CIK 0001452429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:24 UTC GrantStock Option (Right to Buy) · Derivative 55,150 $0.00 Strike: $3.33 $0.00
Disclosure

SEC source: 0001193125-26-232657 · ownership.xml · derivative · entry 1

THOMAS FRANK E · CIK 0001242616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 19, 2026 Filed May 20, 2026 22:03 UTC GrantStock Option (Right to Buy) · Derivative 55,150 $0.00 Strike: $3.33 $0.00
Disclosure

SEC source: 0001193125-26-232933 · ownership.xml · derivative · entry 1

LEFF JONATHAN S · CIK 0001215242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

F2 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 55,150 $0.00 Strike: $3.33 $0.00
Disclosure

SEC source: 0001193125-26-232705 · ownership.xml · derivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:21 UTC GrantStock Option (Right to Buy) · Derivative 55,150 $0.00 Strike: $3.33 $0.00
Disclosure

SEC source: 0001193125-26-232644 · ownership.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 00:46 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 2,000,000 $5.00 $10,000,000.00
Disclosure

SEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 4

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Partners, L.P.

Disclosed balance after: 6,207,982

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 00:46 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 831,978 $5.00 $4,159,890.00
Disclosure

SEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 3

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Healthcare Innovations Fund, L.P.

Disclosed balance after: 8,153,107

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 00:46 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 1,084,012 $5.00 $5,420,060.00
Disclosure

SEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 2

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P.

Disclosed balance after: 10,622,957

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 00:46 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 1,084,010 $5.00 $5,420,050.00
Disclosure

SEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Private Design Fund III, L.P.

Disclosed balance after: 10,622,928

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 21:30 UTC PurchaseCommon Stock 5,000 $5.00 $25,000.00
Disclosure

SEC source: 0001193125-26-085514 · ownership.xml · nonDerivative · entry 1

THOMAS FRANK E · CIK 0001242616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,000

F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 21:30 UTC PurchaseCommon Stock 5,000 $5.00 $25,000.00
Disclosure

SEC source: 0001193125-26-085510 · ownership.xml · nonDerivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 21:30 UTC PurchaseCommon Stock 100,000 $5.00 $500,000.00
Disclosure

SEC source: 0001193125-26-085515 · ownership.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,798

F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 17:03 UTC
Celano MichaelChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 225,622 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001193125-26-024824 · ownership.xml · derivative · entry 2

Celano Michael · CIK 0001377582 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,622

Underlying: Common Stock · 225,622 shares

Expires 2036-01-26

F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 17:03 UTC
Celano MichaelChief Financial Officer
GrantCommon Stock 37,604 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-024824 · ownership.xml · nonDerivative · entry 1

Celano Michael · CIK 0001377582 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,785

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 22:04 UTC
Shankar GopiChief Development Officer
GrantStock Option (Right to Buy) · Derivative 153,822 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001193125-26-024833 · ownership.xml · derivative · entry 2

Shankar Gopi · CIK 0001965014 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,822

Underlying: Common Stock · 153,822 shares

Expires 2036-01-26

F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 22:04 UTC
Shankar GopiChief Development Officer
GrantCommon Stock 25,637 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-024833 · ownership.xml · nonDerivative · entry 1

Shankar Gopi · CIK 0001965014 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,443

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 22:04 UTC
Clayton RussellChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 153,822 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001193125-26-024832 · ownership.xml · derivative · entry 2

Clayton Russell · CIK 0001530072 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,822

Underlying: Common Stock · 153,822 shares

Expires 2036-01-26

F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 22:04 UTC
Clayton RussellChief Medical Officer
GrantCommon Stock 25,637 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-024832 · ownership.xml · nonDerivative · entry 1

Clayton Russell · CIK 0001530072 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,443

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 22:04 UTC
BEN-MAIMON CAROLEDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 600,600 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001193125-26-024826 · ownership.xml · derivative · entry 7

BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,600

Underlying: Common Stock · 600,600 shares

Expires 2036-01-26

F7 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 22:04 UTC
BEN-MAIMON CAROLEDirector · President and CEO
GrantCommon Stock 100,100 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-024826 · ownership.xml · nonDerivative · entry 1

BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,276

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
July 31, 2025 Filed Aug 4, 2025 22:28 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 2,599,932 $3.20 $8,319,782.40
Disclosure

SEC source: 0001193805-25-001155 · e664762_4-larimar.xml · nonDerivative · entry 3

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Healthcare Innovations Fund, L.P.

Disclosed balance after: 7,321,129

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
July 31, 2025 Filed Aug 4, 2025 22:28 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 3,387,539 $3.20 $10,840,124.80
Disclosure

SEC source: 0001193805-25-001155 · e664762_4-larimar.xml · nonDerivative · entry 2

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P.

Disclosed balance after: 9,538,945

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
July 31, 2025 Filed Aug 4, 2025 22:28 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 3,387,529 $3.20 $10,840,092.80
Disclosure

SEC source: 0001193805-25-001155 · e664762_4-larimar.xml · nonDerivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Private Design Fund III, L.P.

Disclosed balance after: 9,538,918

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
May 13, 2025 Filed May 14, 2025 20:33 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001062993-25-009379 · form4.xml · derivative · entry 1

Truitt Joseph · CIK 0001452429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 13, 2025 Filed May 14, 2025 20:32 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001062993-25-009377 · form4.xml · derivative · entry 1

THOMAS FRANK E · CIK 0001242616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 13, 2025 Filed May 14, 2025 20:32 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001062993-25-009376 · form4.xml · derivative · entry 1

LEFF JONATHAN S · CIK 0001215242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

F2 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

Read SEC document
May 13, 2025 Filed May 14, 2025 20:34 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001062993-25-009380 · form4.xml · derivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 13, 2025 Filed May 14, 2025 20:33 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001062993-25-009378 · form4.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 13, 2025 Filed May 15, 2025 23:44 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $1.88 $0.00
Disclosure

SEC source: 0001193805-25-000672 · e664519_4-larimar.xml · derivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Management Company, L.P.

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F2 · derivative.exercise_date: The option was granted on May 13, 2025 and is scheduled to vest on the earlier of May 13, 2026 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer.

F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 16:15 UTC
Celano MichaelChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 205,111 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001062993-25-001077 · form4.xml · derivative · entry 2

Celano Michael · CIK 0001377582 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,111

Underlying: Common Stock · 205,111 shares

Expires 2035-01-22

F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 16:15 UTC
Celano MichaelChief Financial Officer
GrantCommon Stock 34,185 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-001077 · form4.xml · nonDerivative · entry 1

Celano Michael · CIK 0001377582 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,181

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 21:16 UTC
Shankar GopiChief Development Officer
GrantStock Option (Right to Buy) · Derivative 139,838 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001062993-25-001080 · form4.xml · derivative · entry 2

Shankar Gopi · CIK 0001965014 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,838

Underlying: Common Stock · 139,838 shares

Expires 2035-01-22

F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 21:16 UTC
Shankar GopiChief Development Officer
GrantCommon Stock 23,306 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-001080 · form4.xml · nonDerivative · entry 1

Shankar Gopi · CIK 0001965014 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,806

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 21:16 UTC
Clayton RussellChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 139,838 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001062993-25-001079 · form4.xml · derivative · entry 2

Clayton Russell · CIK 0001530072 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,838

Underlying: Common Stock · 139,838 shares

Expires 2035-01-22

F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 21:16 UTC
Clayton RussellChief Medical Officer
GrantCommon Stock 23,306 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-001079 · form4.xml · nonDerivative · entry 1

Clayton Russell · CIK 0001530072 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,806

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 21:15 UTC
BEN-MAIMON CAROLEDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 546,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001062993-25-001078 · form4.xml · derivative · entry 5

BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 546,000

Underlying: Common Stock · 546,000 shares

Expires 2035-01-22

F5 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 21:15 UTC
BEN-MAIMON CAROLEDirector · President and CEO
GrantCommon Stock 91,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-001078 · form4.xml · nonDerivative · entry 1

BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,208

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:57 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $7.07 $0.00
Disclosure

SEC source: 0001062993-24-011569 · form4.xml · derivative · entry 1

Truitt Joseph · CIK 0001452429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:58 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $7.07 $0.00
Disclosure

SEC source: 0001062993-24-011572 · form4.xml · derivative · entry 1

THOMAS FRANK E · CIK 0001242616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:57 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $7.07 $0.00
Disclosure

SEC source: 0001062993-24-011571 · form4.xml · derivative · entry 1

LEFF JONATHAN S · CIK 0001215242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

F2 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:57 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $7.07 $0.00
Disclosure

SEC source: 0001062993-24-011570 · form4.xml · derivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:56 UTC GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $7.07 $0.00
Disclosure

SEC source: 0001062993-24-011568 · form4.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F2 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Read SEC document
May 29, 2024 Filed Jun 3, 2024 22:31 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $7.07 $0.00
Disclosure

SEC source: 0001193805-24-000743 · e663682_4-larimar.xml · derivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Management Company, L.P.

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F2 · derivative.exercise_date: The option was granted on May 29, 2024 and is scheduled to vest on the earlier of May 29, 2025 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer.

F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").

F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 16, 2024 Filed Feb 16, 2024 19:37 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 1,430,205 $8.74 $12,499,991.70
Disclosure

SEC source: 0001193805-24-000245 · e619284_4-larimar.xml · nonDerivative · entry 3

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Partners, L.P.

Disclosed balance after: 4,207,982

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 16, 2024 Filed Feb 16, 2024 19:37 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 1,430,206 $8.74 $12,500,000.44
Disclosure

SEC source: 0001193805-24-000245 · e619284_4-larimar.xml · nonDerivative · entry 2

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P.

Disclosed balance after: 6,151,406

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document
February 16, 2024 Filed Feb 16, 2024 19:37 UTC
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
PurchaseCommon Stock 1,430,206 $8.74 $12,500,000.44
Disclosure

SEC source: 0001193805-24-000245 · e619284_4-larimar.xml · nonDerivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization

Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Deerfield Private Design Fund III, L.P.

Disclosed balance after: 6,151,389

F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.